Cargando…
Serum BRD2 autoantibody in hepatocellular carcinoma and its detection using mimotope peptide-conjugated BSA
Tumor-associated (TA) autoantibodies are considered to be promising biomarkers for the early detection of cancer, prior to the development of clinical symptoms. In the present study, a novel TA autoantibody was detected, which may prove to be useful as a diagnostic marker of human HCC using an HBx-t...
Autores principales: | Heo, Chang-Kyu, Lim, Won-Hee, Park, Inseo, Choi, Yon-Sik, Lim, Kook-Jin, Cho, Eun-Wie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9635863/ https://www.ncbi.nlm.nih.gov/pubmed/36321789 http://dx.doi.org/10.3892/ijo.2022.5448 |
Ejemplares similares
-
Cyclic Peptide Mimotopes for the Detection of Serum Anti–ATIC Autoantibody Biomarker in Hepato-Cellular Carcinoma
por: Heo, Chang-Kyu, et al.
Publicado: (2020) -
Serum anti-EIF3A autoantibody as a potential diagnostic marker for hepatocellular carcinoma
por: Heo, Chang-Kyu, et al.
Publicado: (2019) -
Identification of anti-SF3B1 autoantibody as a diagnostic marker in patients with hepatocellular carcinoma
por: Hwang, Hai-Min, et al.
Publicado: (2018) -
Identification of Peptide Mimotope Ligands for Natalizumab
por: Ruff, Laura E., et al.
Publicado: (2018) -
Tumor-associated autoantibodies as diagnostic and prognostic biomarkers
por: Heo, Chang-Kyu, et al.
Publicado: (2012)